AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Li, DN Seidel, A Pritchard, MP Wolf, CR Friedberg, T
Citation: Dn. Li et al., Polymorphisms in P450CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol, PHARMACOGEN, 10(4), 2000, pp. 343-353

Authors: Murphy, P Pritchard, MP Smith, B
Citation: P. Murphy et al., The destination product and its impact on traveller perceptions, TOUR MANAGE, 21(1), 2000, pp. 43-52

Authors: Lightning, LK Jones, JP Friedberg, T Pritchard, MP Shou, M Rushmore, TH Trager, WF
Citation: Lk. Lightning et al., Mechanism-based inactivation of cytochrome P450 3A4 by L-754,394, BIOCHEM, 39(15), 2000, pp. 4276-4287

Authors: Fowler, SM Riley, RJ Pritchard, MP Sutcliffe, MJ Friedberg, T Wolf, CR
Citation: Sm. Fowler et al., Amino acid 305 determines catalytic center accessibility in CYP3A4, BIOCHEM, 39(15), 2000, pp. 4406-4414

Authors: Friedberg, T Pritchard, MP Bandera, M Hanlon, SP Yao, D McLaughlin, LA Ding, S Burchell, B Wolf, CR
Citation: T. Friedberg et al., Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: An intralaboratory comparison, DRUG METAB, 31(2), 1999, pp. 523-544

Authors: Pritchard, MP Havitz, ME Howard, DR
Citation: Mp. Pritchard et al., Analyzing the commitment-loyalty link in service contexts, J ACAD MARK, 27(3), 1999, pp. 333-348

Authors: Li, DN Pritchard, MP Hanlon, SP Burchell, B Wolf, CR Friedberg, T
Citation: Dn. Li et al., Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism, J PHARM EXP, 289(2), 1999, pp. 661-667

Authors: Koenigs, LL Peter, RM Hunter, AP Haining, RL Rettie, AE Friedberg, T Pritchard, MP Shou, M Rushmore, TH Trager, WF
Citation: Ll. Koenigs et al., Electrospray ionization mass spectrometric analysis of intact cytochrome P450: Identification of tienilic acid adducts to P450 2C9, BIOCHEM, 38(8), 1999, pp. 2312-2319

Authors: Friedberg, T Henderson, CJ Pritchard, MP Wolf, CR
Citation: T. Friedberg et al., In vivo and in vitro recombinant DNA technology as a powerful tool in drugdevelopment, HANDBOOK OF DRUG METABOLISM, 1999, pp. 321-362
Risultati: 1-9 |